Patent Assignment
Reel/Frame 015819/0595
Contribution Agreement
Recorded: 2005-03-27
Pages: 43
Assignor
ICN PHARMACEUTICALS, INC.
Executed: 2002-08-20
Assignee
RIBAPHARM INC.
3300 HYLAND AVENUE, COSTA MESA, CALIFORNIA, 92626
Covered Properties
(9)
Sugar Modified Nucleosides and Oligonucleotides
Patent:
5,681,940 →
Application:
08/333,545 →
Control of CD44 Gene Expression for Therapeutic Use
Patent:
5,990,299 →
Application:
08/514,542 →
Methods and Compositions for Regulation of CD28 Expression
Patent:
5,932,556 →
Application:
08/529,878 →
Oligonucleotide Analogs with an Amino Acid or a Modified Amino Alchol Residue
Patent:
5,969,135 →
Application:
08/551,947 →
Sugar Modified Nucleosides and Their Use for Synthesis of Oligonucleotides
Patent:
5,712,378 →
Application:
08/552,363 →
Carbohydrate Conjugated Bio-Active Compounds
Patent:
5,723,589 →
Application:
08/576,817 →
Conformationally Locked Nucleosides and Oligonuceotides
Patent:
6,083,482 →
Application:
09/309,742 →
Novel Nucleosides Having Bicyclic Sugar Moiety
Patent:
6,403,566 →
Application:
09/451,708 →
Treatment of Viral Infections Using the L-Isomer of Ribavirin
Patent:
6,518,253 →
Application:
09/471,513 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 27, 1994
From: WANG, GUANGYI; RAMASAMY, KANDASAMY; SEIFERT, WILFRIED E.
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 007379/0284 →
Assignment of Assignor's Interest
Aug 14, 1995
From: RUZDIJIC, SABERA; PIETRZKOWSKI, ZBIGNIEW; CIESLAK, DARIUSZ
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 008044/0575 →
Assignment of Assignor's Interest
Nov 2, 1995
From: RAMASAMY, KANDASAMY; SEIFERT, WILFRIED
To: ICN PHARMACUETICALS
Reel/Frame 007994/0389 →
Assignment of Assignor's Interest
Nov 2, 1995
From: WANG, GUANGYI
To: ICN PHARMACEUTICALS
Reel/Frame 007952/0854 →
Assignment of Assignor's Interest
Dec 21, 1995
From: MILJKOVIC, DUSAN; PIETRKOWSKI, ZBIGNIEW; GUNIC, ESMIR; SEIFERT, WILFRIED
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 008051/0069 →
Assignment of Assignor's Interest
Jun 28, 1999
From: WANG, GUANGYI
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 010054/0291 →
Assignment of Assignor's Interest
Aug 27, 1999
From: TAM, ROBERT C.
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 010197/0726 →
Assignment of Assignor's Interest
Feb 8, 2000
From: TAM, ROBERT
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 010587/0399 →
Assignment of Assignor's Interest
Mar 25, 2002
From: WANG, GUANGYI
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 012748/0271 →
Change of Name
Aug 24, 2005
From: RIBAPHARM INC.
To: VALEANT RESEARCH & DEVELOPMENT
Reel/Frame 016446/0026 →
Change of Name
Sep 27, 2005
From: RIBAPHARM INC.
To: VALEANT RESEARCH & DEVELOPMENT
Reel/Frame 016580/0695 →
Merger
Jan 28, 2010
From: VALEANT RESEARCH & DEVELOPMENT
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 023861/0740 →
Assignment of Assignor's Interest
Apr 14, 2010
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: MDRNA, INC.
Reel/Frame 024233/0034 →
Security Agreement (Patents)
Apr 28, 2010
From: MDRNA, INC. FKA NASTECH PHARMACEUTICAL COMPANY INC.
To: CEQUENT PHARMACEUTICALS, INC.
Reel/Frame 024300/0825 →
Release of Security Interest
Jul 30, 2010
From: CEQUENT PHARMACEUTICALS, INC.
To: MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
Reel/Frame 024767/0466 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Change of Name
Jun 27, 2011
From: MDRNA, INC.
To: MARINA BIOTECH, INC.
Reel/Frame 026509/0166 →
Security Agreement
Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Security Agreement
Feb 15, 2012
From: MARINA BIOTECH, INC; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
Reel/Frame 027712/0200 →
Security Agreement
May 13, 2013
From: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: MONSANTO COMPANY
Reel/Frame 030401/0461 →
Release of Security Interest
Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →